Overview
Ultralife Q3 revenue rises 21.5% yr/yr, driven by Electrochem acquisition
Company reports Q3 GAAP EPS of ($0.07), down from $0.02 last year
Ultralife incurs $1.0 mln operating loss due to one-time costs and lower margins
Outlook
Company expects annual savings of $0.8 mln from Calgary facility closure by Q1 2026
Ultralife intensifies lean initiatives to improve supply chain resiliency
Company aims to advance new products into production and capitalize on large programs
Result Drivers
ELECTROCHEM ACQUISITION - Revenue growth driven by inclusion of Electrochem Solutions, boosting Battery & Energy Products sales
SUPPLY CHAIN ISSUES - Manufacturing inefficiencies and delayed orders impacted profitability, per CEO Mike Manna
CALGARY FACILITY CLOSURE - One-time costs related to closing facility affected operating income
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | $43.37 mln | ||
Q3 EPS | -$0.07 | ||
Q3 Net Income | -$1.25 mln | ||
Q3 Adjusted EBITDA | $2.05 mln | ||
Q3 Operating Expenses | $10.57 mln | ||
Q3 Operating Income | -$951,000 | ||
Q3 Pretax Profit | -$1.75 mln |
Press Release: ID:nGNX4jWF2K
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)